Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.450
-0.030 (-1.21%)
At close: Dec 24, 2025
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 913.15 million as of December 26, 2025. Its market cap has increased by 30.12% in one year.
Market Cap
913.15M
Enterprise Value
1.45B
Revenue
627.22M
Ranking
n/a
PE Ratio
162.65
Stock Price
2.45
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 913.15M, an increase of 246.19%. That is a compound annual growth rate of 12.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 913.15M | -15.59% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | 861.69M | 15.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 82.72B |
| Pro Medicus | 23.58B |
| Cochlear | 17.13B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.09B |
| Ansell | 5.05B |
| Telix Pharmaceuticals | 4.03B |
| Mesoblast | 3.72B |